Cue Biopharma Inc
NASDAQ:CUE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cue Biopharma Inc
NASDAQ:CUE
|
US |
|
C
|
Coinbase Global Inc
BCBA:COIN
|
US |
|
S
|
Sekisui House Ltd
XMUN:SPH1
|
JP |
|
R
|
Republic Services Inc
F:RPU
|
US |
|
G
|
Goldman Sachs Group Inc
XMUN:GOS
|
US |
Shareholder Yield
Current shareholder yield for CUE is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
CUE Price
Cue Biopharma Inc
| Average Annual Return | -37.31% |
| Standard Deviation of Annual Returns | 38.73% |
| Max Drawdown | -99% |
| Market Capitalization | 56.4m USD |
| Shares Outstanding | 1 577 383 |
| Percentage of Shares Shorted | 7.75% |
CUE Return Decomposition
Main factors of price return
Stock Splits
CUE's latest stock split occurred on Apr 24, 2026
The company executed a 1-for-30 stock split, meaning that for every 30 shares held, investors received 1 new share.
Before the split, CUE traded at 0.5542 per share. Afterward, the share price was about 17.695.
The adjusted shares began trading on Apr 24, 2026. This was the only stock split in CUE's history.
